NAD+ (Nicotinamide Adenine Dinucleotide) – Comprehensive Research Overview (2026)
NAD+ (Nicotinamide Adenine Dinucleotide) is an essential coenzyme found in every living cell, central to energy metabolism, DNA repair, and cellular signaling. NAD+ levels decline significantly with age, contributing to mitochondrial dysfunction, metabolic disease, and accelerated aging. NAD+ and its precursors (NMN, NR) are among the most researched compounds in longevity science, with growing clinical evidence for metabolic, cardiovascular, neurological, and anti-aging benefits.
→ View NAD+ (for laboratory research use only)
Mechanism of Action
- Serves as a critical electron carrier in the mitochondrial electron transport chain (ATP production).
- Activates sirtuins (SIRT1–7), key longevity enzymes regulating gene expression, inflammation, and metabolism.
- Activates PARP enzymes for DNA repair.
- Regulates CD38 and NAMPT activity in the NAD+ salvage pathway.
- Modulates circadian clock function and cellular stress responses.
Clinical Evidence and Research Findings
Multiple human trials with NAD+ precursors (NMN, NR) demonstrate safe and effective NAD+ elevation in blood and tissues. Clinical signals include improved muscle function, insulin sensitivity, cardiovascular markers, and cognitive performance in aging populations. Direct IV NAD+ infusions are used clinically for addiction recovery, fatigue, and neurological support. Research is rapidly expanding across metabolic, neurological, and longevity applications.
→ Interested in researching NAD+? View Product Options
Benefits (Research & Clinical Observations)
- Enhanced mitochondrial energy production
- Sirtuin activation and epigenetic regulation
- Improved DNA repair capacity
- Metabolic and insulin sensitivity improvements
- Neuroprotection and cognitive support
- Anti-aging and longevity pathway activation
Typical Dosing Protocols (Research)
- IV infusion (clinical): 250–1,000 mg over 2–4 hours, 1–5× per week
- Subcutaneous (research): 100–500 mg daily
- Oral precursors (NMN/NR): 250–1,000 mg daily (more bioavailable orally than NAD+ itself)
Safety Profile and Side Effects
NAD+ has an excellent safety profile across decades of use. IV infusion common side effects: flushing, chest tightness, nausea (rate-dependent; resolve with slower infusion). Oral precursors are very well tolerated.
NAD+ vs NMN vs NR – Quick Comparison
| Aspect | NAD+ (direct) | NMN | NR |
|---|---|---|---|
| Oral Bioavailability | Low | High | High |
| IV/SubQ Use | Yes (clinical) | Yes (research) | Less common |
| Speed of Action | Fastest (IV) | Moderate | Moderate |
| Cost | Higher | Moderate | Lower |
Summary
NAD+ is a foundational coenzyme with central roles in energy metabolism, DNA repair, and longevity signaling. Its age-related decline and the growing clinical evidence for NAD+ restoration make it one of the most important targets in aging and metabolic research. As with all compounds in this library, research use should comply with institutional guidelines and applicable regulations.
For Laboratory Research Use View NAD+ →
Disclaimer This overview is strictly educational and based on publicly available scientific literature as of April 2026. It does not constitute medical advice. Always consult a qualified healthcare professional and comply with all applicable laws and regulations.